Targeting of Glycine Site on NMDA Receptor as a Possible New Strategy for Autism Treatment

Effects of sarcosine, a glycine transporter type 1 inhibitor, in two mouse seizure models

(2014) Katarzyna Socała et al.   Pharmacological Reports

Leptin as a new approach for treatment for autism and epilepsy, a hypothesis with clinical implications

(2010) Ahmad Ghanizadeh   BRAIN & DEVELOPMENT

Transplantation of GABAergic cell line as a novel hypothesized treatment for autism

(2010) Ahmad Ghanizadeh   EPILEPSY & BEHAVIOR

Rett Syndrome Microglia Damage Dendrites and Synapses by the Elevated Release of Glutamate

(2010) I. Maezawa et al.   JOURNAL OF NEUROSCIENCE

Presynaptic Glycine Receptors Influence Plasma Membrane Potential and Glutamate Release

(2010) Tatyana V. Waseem et al.   NEUROCHEMICAL RESEARCH

Neuroprotection by a novel NMDAR functional glycine site partial agonist, GLYX-13

(2009) Patric K. Stanton et al.   NEUROREPORT

Novel plasma phospholipid biomarkers of autism: Mitochondrial dysfunction as a putative causative mechanism

(2009) Élodie Pastural et al.   PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS

Immune-Glutamatergic Dysfunction as a Central Mechanism of the Autism Spectrum Disorders

(2008) R. Blaylock et al.   CURRENT MEDICINAL CHEMISTRY